Item Type | Name |
Concept
|
Thrombosis
|
Concept
|
Venous Thrombosis
|
Academic Article
|
The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects.
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
Academic Article
|
Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review.
|
Academic Article
|
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.
|
Academic Article
|
The economics of venous thromboembolism prophylaxis: a primer for clinicians.
|
Academic Article
|
Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
|
Academic Article
|
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
|
Academic Article
|
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
|
Academic Article
|
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
|
Academic Article
|
Oral rivaroxaban for symptomatic venous thromboembolism.
|
Academic Article
|
Thrombosis: a major contributor to global disease burden.
|
Academic Article
|
Thrombosis: a major contributor to global disease burden.
|
Academic Article
|
On World Thrombosis Day.
|
Academic Article
|
Global Burden of Thrombosis: Epidemiologic Aspects.
|
Academic Article
|
Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
|
Academic Article
|
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
|
Academic Article
|
Optimal therapeutic level of heparin therapy in patients with venous thrombosis.
|
Academic Article
|
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
|
Academic Article
|
Pharmacokinetics and dynamics of heparin in patients with proximal vein thrombosis.
|
Academic Article
|
Impedance plethysmography for suspected deep-vein thrombosis.
|
Academic Article
|
Cost effectiveness of diagnosis of deep vein thrombosis in symptomatic patients.
|
Academic Article
|
Oral anticoagulant therapy.
|
Academic Article
|
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis.
|
Academic Article
|
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society.
|
Academic Article
|
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.
|
Academic Article
|
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.
|
Academic Article
|
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer.
|
Academic Article
|
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.
|
Academic Article
|
Idraparinux versus standard therapy for venous thromboembolic disease.
|
Academic Article
|
Extended prophylaxis of venous thromboembolism with idraparinux.
|
Academic Article
|
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
|
Academic Article
|
On World Thrombosis Day.
|
Academic Article
|
Factor XI antisense oligonucleotide for prevention of venous thrombosis.
|
Academic Article
|
Global public awareness of venous thromboembolism.
|
Academic Article
|
New paradigms in venous thromboprophylaxis of medically ill patients.
|
Academic Article
|
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
|
Academic Article
|
Heparin therapy for venous thrombosis and pulmonary embolism.
|
Academic Article
|
A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis.
|
Academic Article
|
The diagnosis of clinically suspected venous thrombosis.
|
Academic Article
|
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
|
Academic Article
|
Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
|
Academic Article
|
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group.
|
Academic Article
|
Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review.
|
Academic Article
|
Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility.
|
Academic Article
|
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
|
Academic Article
|
Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings.
|
Academic Article
|
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
|
Academic Article
|
Duration of warfarin in pulmonary embolism.
|
Academic Article
|
Prevention of central venous catheter-associated thrombosis: a meta-analysis.
|
Academic Article
|
Exclusion of first-episode deep-vein thrombosis after-hours using D-dimer.
|
Academic Article
|
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
|
Academic Article
|
Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.
|
Academic Article
|
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
|
Academic Article
|
Epidemiology and pathogenesis of venous thrombosis.
|
Academic Article
|
Clinical features and diagnosis of venous thrombosis.
|
Academic Article
|
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
|
Academic Article
|
Impact of World Thrombosis Day campaign.
|
Academic Article
|
Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
|
Academic Article
|
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
|
Academic Article
|
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
|
Academic Article
|
Hirudin versus heparin and low-molecular-weight heparin: and the winner is...
|
Academic Article
|
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
|
Academic Article
|
Negative D-dimer result to exclude recurrent deep venous thrombosis: a management trial.
|
Academic Article
|
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
|
Academic Article
|
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
|
Academic Article
|
Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop.
|
Academic Article
|
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
|
Academic Article
|
Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group.
|
Academic Article
|
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
|
Academic Article
|
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
|
Academic Article
|
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
|
Academic Article
|
Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement.
|
Academic Article
|
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
|
Academic Article
|
Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis. Clinical validity of negative findings.
|
Academic Article
|
A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
|
Academic Article
|
Duration of anticoagulant treatment for venous thrombosis.
|
Grant
|
THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT
|
Academic Article
|
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients.
|
Academic Article
|
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.
|
Academic Article
|
Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer.
|